PhoenixBio Co.,Ltd. Logo

PhoenixBio Co.,Ltd.

A CRO providing humanized liver mouse models for preclinical drug studies.

6190 | T

Overview

Corporate Details

ISIN(s):
JP3803010002
LEI:
Country:
Japan
Address:
東広島市鏡山三丁目4番1号

Description

PhoenixBio is a contract research organization (CRO) specializing in translational animal models for the pharmaceutical industry. The company's core product is the PXB-mouse®, a proprietary chimeric mouse model featuring a liver that is highly repopulated (over 70%) with functional human hepatocytes. This humanized liver model is utilized globally in preclinical studies to evaluate drug metabolism, pharmacokinetics, and toxicity. In addition to supplying the PXB-mouse® and primary human hepatocytes (PXB-cells®), PhoenixBio provides comprehensive, quality-controlled contract study services to support drug discovery and early development projects.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-14 08:12
確認書
Japanese 8.1 KB
2025-11-14 08:10
半期報告書-第25期(2025/04/01-2026/03/31)
Japanese 163.4 KB
2025-07-01 04:29
臨時報告書
Japanese 22.2 KB
2025-06-25 04:07
内部統制報告書-第24期(2024/04/01-2025/03/31)
Japanese 22.3 KB
2025-06-25 04:04
確認書
Japanese 8.0 KB
2025-06-25 04:02
有価証券報告書-第24期(2024/04/01-2025/03/31)
Japanese 912.3 KB
2025-05-23 05:02
臨時報告書
Japanese 19.1 KB
2025-05-14 09:55
臨時報告書
Japanese 20.1 KB
2025-03-03 02:24
臨時報告書
Japanese 19.0 KB
2024-11-14 08:06
確認書
Japanese 8.0 KB
2024-11-14 08:04
半期報告書-第24期(2024/04/01-2025/03/31)
Japanese 165.5 KB
2024-07-02 02:35
臨時報告書
Japanese 18.4 KB
2024-07-01 07:59
臨時報告書
Japanese 21.4 KB
2024-06-27 03:06
内部統制報告書-第23期(2023/04/01-2024/03/31)
Japanese 22.1 KB
2024-06-27 03:04
確認書
Japanese 8.0 KB

Automate Your Workflow. Get a real-time feed of all PhoenixBio Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for PhoenixBio Co.,Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for PhoenixBio Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Evogene Ltd. Logo
A computational biology company using AI to develop life-science products.
Israel
EVGN
Evotec SE Logo
A life science company offering drug discovery and development partnership solutions.
Germany
EVT
EXICURE, INC. Logo
Early-stage biotech developing nucleic acid therapies based on SNA technology.
United States of America
XCUR
EyeGene,Inc Logo
Develops gene/cell therapies for age-related diseases and preventive vaccines.
South Korea
185490
Femtobiomed Inc. Logo
Develops a non-viral intracellular delivery platform for cell and gene therapy.
South Korea
327610
Develops AI data center campuses with co-located hybrid power generation.
United States of America
FRMI
Fluicell AB Logo
A biotech firm creating engineered tissues for regenerative medicine and drug development.
Sweden
FLUI
Foghorn Therapeutics Inc. Logo
Develops medicines targeting the chromatin regulatory system for oncology.
United States of America
FHTX
Fortrea Holdings Inc. Logo
A global CRO providing clinical development and patient access solutions to life sciences.
United States of America
FTRE
FUSION ANTIBODIES PLC Logo
CRO providing end-to-end services for preclinical antibody development.
United Kingdom
FAB

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.